Nouscom AG of Switzerland has promoted Richard Davis to the position of chief operating officer. He joined the company in September 2020 as chief business officer. Nouscom is developing personalised cancer vaccines. Dr Davis was previously head of global oncology venture and transactions business at Johnson and Johnson Innovation.
He has also held financing and business development roles at the Wellcome Trust in the UK. Dr Davis began his career in clinical development at Pharmagene after obtaining a PhD in pharmacology from the University of Leicester, UK.
Nouscom announced the appointment on 23 May 2022.
Copyright 2022 Evernow Publishing Ltd